Dennis Ross-Degnan, Sc.D., is Associate Professor at the Department of Ambulatory Care and Prevention (DACP) at Harvard Medical School and Director of Research at Harvard Pilgrim Health Care. He holds a doctorate in health policy and management from the Harvard School of Public Health. Dr. Ross-Degnan is one of the global leaders in improving use of medicines. His career has focused on improving health systems in the US and developing countries, including research on the factors underlying use of medicines, impacts of pharmaceutical policies on utilization and clinical outcomes, interventions to improve quality of care, and appropriate methods for pharmaceutical research. In 1990, he co-founded the International Network for Rational Use of Drugs (INRUD), a global network of academics, health managers, and policymakers involved in developing and testing interdisciplinary interventions to improve use of medicines. In recognition of these efforts, he was awarded the 2005 HMS Klaus Peter International Teaching Award. Dr. Ross-Degnan has consulted extensively with the World Health Organization on issues related to pharmaceutical access and appropriate use, and co-directs the WHO Collaborating Center on Pharmaceutical Policy based jointly at DACP and the Boston University Center for International Health.
Select publications:
- Ross-Degnan D, Laing R, Quick J, Ali HM, Ofori-Adjei D, Salako L, Santoso B. A strategy for promoting improved pharmaceutical use: The International Network for Rational Use of Drugs. Soc. Sci. Med. 1992; 35(1): 1329-1341.
- Ross-Degnan D, Soumerai S, Goel P, Bates J, Makhulo J, Dondi N, Sutoto, Daryono A, Ferraz-Tabor L, Hogan R. A controlled trial of the impact of persuasive face-to-face education on diarrhea treatment in pharmacies in two developing countries. Health Policy Plan 1996; 11(3): 308-18.
- Ross-Degnan D, Simoni-Wastila L, Brown J, Gao X, Mah C, Cosler L, Fanning T, Gallagher P, Salzman C, Shader RI, Inui T, Soumerai S. A controlled study of the effects of state surveillance on volume and appropriateness of benzodiazepine prescribing in a Medicaid population. Int J Psychiatry Med. 2004; 34(2): 103-23.
- Pearson SA, Soumerai S, Mah C, Zhang F, Simoni-Wastila L, Salzman C, Cosler LE, Fanning T, Gallagher P, Ross-Degnan D. Racial disparities in access after regulatory surveillance of benzodiazepines. Arch Int Med. 2006; 166 (5): 572-9.
- Grant R, Adams AS, Mah Trinacty C, Zhang F, Kleinman K, Soumerai SB, Meigs JB, Ross-Degnan D. Relationship between patient medication adherence and subsequent clinical inertia in Type 2 diabetes glycemic management. Diabetes Care 2007 (in press)
- Wharam F, Landon BE, Kleinman K, Soumerai S, Ross-Degnan D. Emergency department use and subsequent hospitalizations among members of a high deductible health plan. JAMA 2007 (in press)
|
